Single-cell genomics in AML: extending the frontiers of AML research
Blood · 26.01.2023 · 141 (4) · 345-355
DOI: 10.1182/blood.2021014670 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Blood, erschienen am 26.01.2023. Verfasst von Asiri Ediriwickrema und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, CA. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIA NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
The era of genomic medicine has allowed acute myeloid leukemia (AML) researchers to improve disease characterization, optimize risk-stratification systems, and develop new treatments. Although there has been significant progress, AML remains a lethal cancer because of its remarkably complex and plastic cellular architecture. This degree of heterogeneity continues to pose a major challenge, because it limits the ability to identify and therefore eradicate the cells responsible for leukemogenesis and treatment failure. In recent years, the field of single-cell genomics has led to unprecedented strides in the ability to characterize cellular heterogeneity, and it holds promise for the study of AML. In this review, we highlight advancements in single-cell technologies, outline important shortcomings in our understanding of AML biology and clinical management, and discuss how single-cell genomics can address these shortcomings as well as provide unique opportunities in basic and translational AML research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, CA.
- Cancer Institute, Stanford University School of Medicine, Stanford, CA.
- Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA.
- Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA.
ORCID-Profile: Asiri Ediriwickrema, Andrew J Gentles, Ravindra Majeti
Förderung
- NCI NIH HHS
- NIA NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Ediriwickrema, A., Gentles, A. J., & Majeti, R. (2023). Single-cell genomics in AML: extending the frontiers of AML research. Blood, 141(4), 345-355. https://doi.org/10.1182/blood.2021014670
Vancouver
Ediriwickrema A, Gentles AJ, Majeti R. Single-cell genomics in AML: extending the frontiers of AML research. Blood. 2023;141(4):345-355. doi:10.1182/blood.2021014670
BibTeX
@article{Ediriwickrema2023,
author = {Ediriwickrema, Asiri and Gentles, Andrew J and Majeti, Ravindra},
title = {Single-cell genomics in AML: extending the frontiers of AML research},
journal = {Blood},
year = {2023},
volume = {141},
number = {4},
pages = {345--355},
doi = {10.1182/blood.2021014670}
}
EUVIMED